{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:06:35Z","timestamp":1761156395838,"version":"3.37.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Canadian Institutes of Health Research (CIHR)","award":["MOP 119473"],"award-info":[{"award-number":["MOP 119473"]}]},{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.10.095","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T01:31:00Z","timestamp":1511141460000},"page":"7139-7146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity"],"prefix":"10.1016","volume":"35","author":[{"given":"R.","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Brownlie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Latimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gerdts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"van Drunen Littel-van den Hurk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.095_b0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1586\/ers.11.32","article-title":"Progress in the development of human parainfluenza virus vaccines","volume":"5","author":"Schmidt","year":"2011","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.vaccine.2017.10.095_b0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/CMR.16.2.242-264.2003","article-title":"Parainfluenza viruses","volume":"16","author":"Henrickson","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2017.10.095_b0015","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI25669","article-title":"Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease","volume":"115","author":"Moscona","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2017.10.095_b0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0264-410X(91)90037-7","article-title":"Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats","volume":"9","author":"Ambrose","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.095_b0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0264-410X(91)90192-9","article-title":"Protection of cotton rats by immunization with the human parainfluenza virus type 3 fusion (F) glycoprotein expressed on the surface of insect cells infected with a recombinant baculovirus","volume":"9","author":"Hall","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.095_b0030","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/JVI.52.3.828-832.1984","article-title":"Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children","volume":"52","author":"Kasel","year":"1984","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.095_b0035","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1097\/INF.0b013e31822ea24f","article-title":"The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young children","volume":"30","author":"Karron","year":"2011","journal-title":"Pediat Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.10.095_b0040","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/323150","article-title":"Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants","volume":"184","author":"Lee","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.095_b0045","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/infdis\/152.6.1219","article-title":"Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine","volume":"152","author":"Ray","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.095_b0050","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/infdis\/157.4.648","article-title":"Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3","volume":"157","author":"Ray","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.095_b0055","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/JVI.61.11.3416-3423.1987","article-title":"Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity","volume":"61","author":"Spriggs","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.095_b0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jmv.1890180205","article-title":"Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3","volume":"18","author":"Crookshanks-Newman","year":"1986","journal-title":"J Med Virol"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2017.10.095_b0065","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1099\/0022-1317-74-3-471","article-title":"Protection of cotton rats against human parainfluenza virus type 3 by vaccination with a chimeric FHN subunit glycoprotein","volume":"74","author":"Brideau","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.10.095_b0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1099\/vir.0.83300-0","article-title":"Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection","volume":"89","author":"Mapletoft","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.10.095_b0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/01902148109052306","article-title":"The cotton rat as an experimental model of human parainfluenza virus type 3 disease","volume":"2","author":"Murphy","year":"1981","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.vaccine.2017.10.095_b0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4049\/jimmunol.99.1.133","article-title":"Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines","volume":"99","author":"Smith","year":"1967","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.10.095_b0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1099\/vir.0.058461-0","article-title":"Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulation","volume":"95","author":"Garg","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.10.095_b0090","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1099\/vir.0.062570-0","article-title":"Vaccination with the RSV fusion protein formulated with a combination adjuvant induces long-lasting protective immunity","volume":"95","author":"Garg","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.10.095_b0095","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.1016\/j.vaccine.2011.07.135","article-title":"Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets","volume":"29","author":"Polewicz","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.095_b0100","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.vaccine.2014.10.010","article-title":"The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle","volume":"32","author":"Snider","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.095_b0105","doi-asserted-by":"crossref","unstructured":"Garg R, Latimer L, Gerdts V, Potter A, van Drunen Littel-van den Hurk S. The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies. Vaccine 2015.","DOI":"10.1016\/j.vaccine.2015.01.041"},{"key":"10.1016\/j.vaccine.2017.10.095_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12985-016-0512-8","article-title":"S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen","volume":"13","author":"Makadiya","year":"2016","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2017.10.095_b0115","doi-asserted-by":"crossref","first-page":"e0156094","DOI":"10.1371\/journal.pone.0156094","article-title":"Antibody and cytokine responses of koalas (phascolarctos cinereus) vaccinated with recombinant chlamydial major outer membrane protein (MOMP) with two different adjuvants","volume":"11","author":"Khan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.10.095_b0120","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.vaccine.2014.08.037","article-title":"Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses","volume":"32","author":"Khan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.095_b0125","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fmicb.2013.00346","article-title":"Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3","volume":"4","author":"Senchi","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2017.10.095_b0130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.virol.2016.09.023","article-title":"A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus","volume":"499","author":"Garg","year":"2016","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17315244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17315244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T18:33:27Z","timestamp":1693247607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17315244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":26,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17315244"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.095","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}